WatchME Instructional Video: Ultrasound-Guided Botulinum Toxin Injections with Needle In-Plane: Upper Limb Targets - American Academy of Physical Medicine and Rehabilitation

WatchME Instructional Video: Ultrasound-Guided Botulinum Toxin Injections with Needle In-Plane: Upper Limb Targets

Description

This instructional video will cover the rationale, ergonomic challenges, and augmentations forultrasound guidance with needle in-plane technique for upper limb ultrasound guided Botulinum toxininjections. Demonstrations within this video include how to properly performthe procedure for the following upper limb targets: FCR, FCU, all four FDPmuscles (via 1 injection site), all four FDS muscles (via 2 separate injectionsites), and FPL.

Method of Study
Upon viewing this video, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the individual sessions.

Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.

AAPM&R Medical Education Committee:

Steven R. Flanagan, MD, Chair: Disclosed no relevant financial relationships.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.

AAPM&R CME Committee:
Kerrie M. Reed, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.

No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.

FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.

Partial support of this activity has been provided through educational grants from the following companies in accordance with ACCME guidelines: Allergan, Inc.; Ipsen Biopharmaceuticals; Merz USA.

Summary


Availability:	On-Demand
	Expires on Oct 31, 2024


Cost:	Member: $95.00 Non-Member: $135.00 Resident Member: $55.00 Resident Non-Member: $95.00

Credit Offered:

1 CME Credit